What is complicated about it specifically? Terms are pretty standard for a CN
It is also very cheap for a microcap, you can't compare financing a <$100M biotech can get against what Fortescue or the banks are able to raise from the capital markets.
This is a huge vote of confidence from insiders and a much better scenario than anyone could have hoped for.
Ann: Memphasys completes $3m capital raise, page-12
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
